Author Title Type [ Year(Asc)]
Filters: Author is Wang, Ying  [Clear All Filters]
Wang Y, Liu X, Hu T, Li X, Chen Y, Xiao G, Huang J, Chang Y, Zhu Y, Zhang H, et al. Astragalus saponins improves stroke by promoting the proliferation of neural stem cells through phosphorylation of Akt. J Ethnopharmacol. 2021:114224.
Miao R, Dong X, Gong J, Li Y, Guo X, Wang J, Huang Q, Wang Y, Li J, Yang S, et al. Cell landscape atlas for patients with chronic thromboembolic pulmonary hypertension after pulmonary endarterectomy constructed using single-cell RNA sequencing. Aging (Albany NY). 2021;13.
Ren X, Wen W, Fan X, Hou W, Su B, Cai P, Li J, Liu Y, Tang F, Zhang F, et al. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell. 2021.
Newell LF, Williams T, Liu J, Yu Y, Chen Y, Booth GC, Knight RJ, Goslee KR, Cook RJ, Leonard J, et al. Engrafted donor-derived clonal hematopoiesis after allogenic hematopoietic cell transplantation is associated with chronic GVHD requiring immunosuppressive therapy, but no adverse impact on OS or relapse. Transplant Cell Ther. 2021.
Zhang W, Hua Y, Di W, Guo J, Dai Q, Zhao J, Zhang B, Wang Y. Generation of a human induced pluripotent stem cell line (SIAISi011-A) from a 61-year-old Chinese Han healthy female donor. Stem Cell Res. 2021;51:102173.
Guo J, Fang F, Dai Q, Zhang W, Di W, Hu J, Zhao J, Cao J, Wang Y. Generation of a human-derived induced pluripotent stem cell line (SIAISi012-A) from an 82-year-old healthy Chinese Han male. Stem Cell Res. 2021;52:102186.
Zhang W, Di W, Zhao J, Zhang B, Wang Y. Generation of a SIAISi004-A hiPSC line from PBMCs of a 74 year-old Alzheimer's disease woman by non-integrating sendai virus mediated reprogramming. Stem Cell Res. 2021;55:102501.
Guo J, Di W, Zhang W, Dai Q, Zhao J, Deng Y, Wang Y. Generation of an induced pluripotent stem cell line (SIAISi009-A) from a 60-year-old Chinese Han female with mild cognitive impairment (MCI) having two copies of APOE4/4 allele. Stem Cell Res. 2021;51:102198.
Zhang W, Dai Q, Hua Y, Di W, Guo J, Zhao J, Deng Y, Wang Y. Generation of three iPSC cell lines (SIAISi006-A, SIAISi007-A and SIAISi008-A) from a 66-year-old Alzheimer's disease (AD) patient and her two unaffected children from Chinese Han population. Stem Cell Res. 2021;51:102172.
Liu Y, Xue M, Cao D, Qin L, Wang Y, Miao Z, Wang P, Hu X, Shen J, Xiong B. Multi-omics characterization of WNT pathway reactivation to ameliorate BET inhibitor resistance in liver cancer cells. Genomics. 2021.
Qian J-J, Hu X, Wang Y, Zhang Y, Du J, Yang M, Tong H, Bin Qian W-, Wei J, Yu W, et al. CAG regimen for refractory or relapsed adult T-cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study. Cancer Med. 2020.
Yang M, Liu B, Wang Y, Liu Y, Gong X, Gong B, Xu Y, Mi Y, Wang M, Wang J. Chimeric antigen receptor-modified T-cell therapy for bone marrow and skin relapse Philadelphia chromosome-like acute lymphoblastic leukemia: A case report. Medicine (Baltimore). 2020;99(18):e18639.
Yan YI, Qiu Y, Zhao A, Zhao J, Wang Y, Deng Y. Establishment of SIAISi001-A, an induced pluripotent stem cell (iPSC) line from 66-year old mild cognitive impairment (MCI) with two copies of APOE4 gene. Stem Cell Res. 2020;43:101702.
Yan Y, Qiu Y, Zhao A, Zhao J, Wang Y, Deng Y. Establishment of SIAISi002-A, an induced pluripotent stem cell (iPSC) line from 39-year old healthy female donor with a family history of Alzheimer's disease (AD) and two copies of APOE4 gene. Stem Cell Res. 2020;45:101792.
Dai Q, Zhang W, Guo J, Di W, Zhao J, Zhang B, Wang Y. Generation of an induced pluripotent stem cell line (SIAISi003-A) from a 79-year-old patient with Alzheimer's disease having APOE3/4 genetic background. Stem Cell Res. 2020;48:101949.
Wang Y, Yuan S, Sun J, Gong Y, Liu S, Guo R, He W, Kang P, Li R. Inhibitory effect of the TSG-6 on the BMP-4/Smad signaling pathway and odonto/osteogenic differentiation of dental pulp stem cells. Biomed Pharmacother. 2020;128:110266.
Wang Y, Zheng J-P, Luo Y, Wang J, Xu L, Wang J, Sedivy JM, Song Z, Wang H, Ju Z. L1 drives HSC aging and affects prognosis of chronic myelomonocytic leukemia. Signal Transduct Target Ther. 2020;5(1):205.
Zhu M, Chu Y, Shang Q, Zheng Z, Li Y, Cao L, Chen Y, Cao J, Lee OK, Wang Y, et al. Mesenchymal stromal cells pretreated with pro-inflammatory cytokines promote skin wound healing through VEGFC-mediated angiogenesis. Stem Cells Transl Med. 2020.
An C, Feng G, Zhang J, Cao S, Wang Y, Wang N, Lu F, Zhou Q, Wang H. Overcoming Autocrine FGF Signaling-Induced Heterogeneity in Naive Human ESCs Enables Modeling of Random X Chromosome Inactivation. Cell Stem Cell. 2020.
Li H, Yin L, Wang Y, Wang X, Shi M, Cao J, Yan Z, Sang W, Cheng H, Zhu F, et al. Safety and efficacy of chimeric antigen receptor T-cell therapy in relapsed/refractory multiple myeloma with renal impairment. Bone Marrow Transplant. 2020.
Cao Y, Wu H, Zhai W, Wang Y, Li M, Li M, Yang L, Tian Y, Song Y, Li J, et al. A safety consideration of mesenchymal stem cell therapy on COVID-19. Stem Cell Res. 2020;49:102066.
Wang Y, Hu Z, Ma W, Niu Y, Su J, Zhang L, Zhao P. Signal transducer and activator of transcription 3 inhibition alleviates resistance to BRAF inhibition in anaplastic thyroid cancer. Invest New Drugs. 2020.
Fang J, Zhang S, Liu Z, Pan Y, Cao L, Hou P, Chen Y, Zhang Y, Li X, Liu R, et al. Skeletal muscle stem cells confer maturing macrophages anti-inflammatory properties through insulin-like growth factor-2. Stem Cells Transl Med. 2020.
Campione E, Lanna C, Diluvio L, Cannizzaro MVittoria, Grelli S, Galluzzo M, Talamonti M, Annicchiarico-Petruzzelli M, Mancini M, Melino G, et al. Skin immunity and its dysregulation in atopic dermatitis, hidradenitis suppurativa and vitiligo. Cell Cycle. 2020:1-11.
Wang Y, Sano S, Yura Y, Ke Z, Sano M, Oshima K, Ogawa H, Horitani K, Min K-D, Miura-Yura E, et al. Tet2-mediated clonal hematopoiesis in non-conditioned mice accelerates age-associated cardiac dysfunction. JCI Insight. 2020.